As 2024 drew to a close, Englands NICE finalised its guidance for Mounjaro, recommending its use in the primary care setting, for treating adults with a body mass index (BMI) 35 kg/m2 and at least one weight-related co-morbidity, alongside a reduced-calorie diet and increased exercise, with no restriction on treatment duration, equating to a total eligible population of 3.4 million patients [5]
Treatments (Clinical) Clinical management of malnutrition and cachexia involves a multidisciplinary team approach including the physician, registered dietitian, speech-language pathologist (for dysphagia), pharmacist, and social worker
I am very pleased with my purchase of the Bacteriostatic Water, especially with how simple the checkout process was
Novo Nordisk, also suggests that some lawyers think it will be advantageous to stay outside the class action-style lawsuit and proceed with a New Jersey state court Ozempic case
Our Professional Take for 2026: Matching the Method to the Mission So, after laying it all out, what's the verdict in the GHK-Cu oral vs injectable showdown
